Effect of Body Mass Index on Long‐Term Outcomes After Endoscopic Sinus Surgery
The Laryngoscope · 03.08.2026
DOI: 10.1002/lary.70788 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 03.08.2026. Verfasst von Jack Y Ghannam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Mass Eye and Ear, Mass General Brigham, Boston, Massachusetts, USA. Die Arbeit nennt 36 Literaturangaben. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Objectives
Whether body mass index (BMI) influences long‐term clinical outcomes after endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS) remains unclear. We investigated whether BMI is associated with baseline symptom severity, longitudinal postoperative symptom trajectories, and time to revision surgery or biologic use.
Methods
We conducted a longitudinal cohort study of adult CRS patients undergoing ESS at a tertiary care center with 5‐year follow‐up. Preoperative BMI was categorized as normal weight (< 25.0 kg/m 2 ), overweight (25.0–29.9), and obese (≥ 30.0). Outcomes were baseline 22‐item Sinonasal Outcome Test (SNOT‐22) scores, longitudinal SNOT‐22 trajectories analyzed via multivariable linear mixed‐effects models, and time to revision surgery or biologic use via multivariable Cox regression.
Results
Among 664 patients, 35.4% were normal weight, 35.5% overweight, and 29.1% obese. Obese patients had significantly higher baseline SNOT‐22 scores (β, 6.70; 95% CI, 2.56–10.85). A significant BMI‐by‐time interaction ( p = 0.033) revealed that obese patients' symptoms worsened at a greater rate over time, increasing by 0.82 points per year versus normal‐weight patients. Elevated BMI predicted higher revision surgery risk (hazard ratio [HR], 2.41; 95% CI, 1.11–5.22), particularly in patients with nasal polyps (HR, 5.30; 95% CI, 1.45–19.35). Preoperative BMI was not associated with subsequent biologic use (HR, 1.67; 95% CI, 0.64–4.36).
Conclusion
Elevated BMI was associated with worse baseline symptoms, progressive postoperative symptom deterioration, and increased revision risk. Although baseline SNOT‐22 differences were below the minimal clinically important difference (MCID), cumulative longitudinal divergence exceeded the MCID by year 3, indicating that BMI should inform preoperative counseling and postoperative monitoring. Level of Evidence 3.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Mass Eye and Ear, Mass General Brigham, Boston, Massachusetts, USA.
- Harvard/MIT MD-PhD Program, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Surgery, Mass General Brigham, Boston, Massachusetts, USA.
- Center for Surgery and Public Health (CSPH), Department of Surgery, Mass General Brigham, Boston, Massachusetts, USA.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Ghannam, J. Y., Zhou, A. S., Gray, S. T., Shin, J. J., & Metson, R. (2026). Effect of Body Mass Index on Long‐Term Outcomes After Endoscopic Sinus Surgery. The Laryngoscope. https://doi.org/10.1002/lary.70788
Vancouver
Ghannam JY, Zhou AS, Gray ST, Shin JJ, Metson R. Effect of Body Mass Index on Long‐Term Outcomes After Endoscopic Sinus Surgery. The Laryngoscope. 2026. doi:10.1002/lary.70788
BibTeX
@article{Ghannam2026,
author = {Ghannam, Jack Y and Zhou, Allen S and Gray, Stacey T and Shin, Jennifer J and Metson, Ralph},
title = {Effect of Body Mass Index on Long‐Term Outcomes After Endoscopic Sinus Surgery},
journal = {The Laryngoscope},
year = {2026},
doi = {10.1002/lary.70788}
}
EUVIMED